BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1699199)

  • 21. Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors.
    Abdollahi A; Roberts D; Godwin AK; Schultz DC; Sonoda G; Testa JR; Hamilton TC
    Oncogene; 1997 Apr; 14(16):1973-9. PubMed ID: 9150364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of candidate target genes for EVI-1, a zinc finger oncoprotein, using a novel selection strategy.
    Kim JH; Hui P; Yue D; Aycock J; Leclerc C; Bjoring AR; Perkins AS
    Oncogene; 1998 Sep; 17(12):1527-38. PubMed ID: 9794230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EVI-1 zinc finger protein works as a transcriptional activator via binding to a consensus sequence of GACAAGATAAGATAAN1-28 CTCATCTTC.
    Morishita K; Suzukawa K; Taki T; Ihle JN; Yokota J
    Oncogene; 1995 May; 10(10):1961-7. PubMed ID: 7761097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The EVI-1 gene--its role in pathogenesis of human leukemias.
    Jółkowska J; Witt M
    Leuk Res; 2000 Jul; 24(7):553-8. PubMed ID: 10867128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
    Deuel TF; Guan LS; Wang ZY
    Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death.
    Kurokawa M; Mitani K; Yamagata T; Takahashi T; Izutsu K; Ogawa S; Moriguchi T; Nishida E; Yazaki Y; Hirai H
    EMBO J; 2000 Jun; 19(12):2958-68. PubMed ID: 10856240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and characterization of ZNF189, a novel human Krüppel-like zinc finger gene localized to chromosome 9q22-q31.
    Odeberg J; Røsok O; Gudmundsson GH; Ahmadian A; Roshani L; Williams C; Larsson C; Pontén F; Uhlén M; Asheim HC; Lundeberg J
    Genomics; 1998 Jun; 50(2):213-21. PubMed ID: 9653648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
    Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
    Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Leukemogenesis by the AML1/EVI-1 chimeric protein].
    Mitani K; Hirai H
    Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):33-9. PubMed ID: 10643333
    [No Abstract]   [Full Text] [Related]  

  • 30. Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients.
    Aicher WK; Heer AH; Trabandt A; Bridges SL; Schroeder HW; Stransky G; Gay RE; Eibel H; Peter HH; Siebenlist U
    J Immunol; 1994 Jun; 152(12):5940-8. PubMed ID: 8207219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insertional mutagenesis and transformation of hematopoietic stem cells.
    Ihle JN; Morishita K; Matsugi T; Bartholomew C
    Prog Clin Biol Res; 1990; 352():329-37. PubMed ID: 2169632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene.
    Subramaniam M; Hefferan TE; Tau K; Peus D; Pittelkow M; Jalal S; Riggs BL; Roche P; Spelsberg TC
    J Cell Biochem; 1998 Feb; 68(2):226-36. PubMed ID: 9443078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
    Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
    Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein.
    Perkins AS; Fishel R; Jenkins NA; Copeland NG
    Mol Cell Biol; 1991 May; 11(5):2665-74. PubMed ID: 2017172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of EVI-1 in normal hematopoiesis and myeloid malignancies (Review).
    Yuan X; Wang X; Bi K; Jiang G
    Int J Oncol; 2015 Dec; 47(6):2028-36. PubMed ID: 26496831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the transcription factor Evi-1 in human erythroleukemia cell lines and in leukemias.
    Fontenay-Roupie M; Bouscary D; Melle J; Viguié F; Picard F; Guesnu M; Dreyfus F
    Hematol Cell Ther; 1997 Feb; 39(1):5-10. PubMed ID: 9088932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain.
    Tanaka T; Nishida J; Mitani K; Ogawa S; Yazaki Y; Hirai H
    J Biol Chem; 1994 Sep; 269(39):24020-6. PubMed ID: 7929053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The transcription factor Evi-1.
    Hirai H
    Int J Biochem Cell Biol; 1999 Dec; 31(12):1367-71. PubMed ID: 10641791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.
    Delwel R; Funabiki T; Kreider BL; Morishita K; Ihle JN
    Mol Cell Biol; 1993 Jul; 13(7):4291-300. PubMed ID: 8321231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins.
    Palmer S; Brouillet JP; Kilbey A; Fulton R; Walker M; Crossley M; Bartholomew C
    J Biol Chem; 2001 Jul; 276(28):25834-40. PubMed ID: 11328817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.